Abstract
Vesicular drug delivery system are novel means to improve the bioavailability of the encapsulated drug along with numerous advantages over conventional drug delivery systems. Liposomes were first in such type of delivery systems but it was not so successful due to their numerous drawbacks. Niosomes or non ionic surfactant vesicles are formed from self assembly of hydrated surfactant monomers. They are formulated by non ionic surfactants but various ionic amphiphiles like di cetyl phosphate, sodium deoxycholate and stearylamine etc. are also incorporated inorder to achieve a stable vesicular suspension by inducing negative or positive charge. The most striking feature of such delivery system is that it can be used to encapsulate both hydrophobic as well as hydrophilic drug. The emphasis of this type of vesicular drug delivery system is placed over the slow release of drug in a controlled manner, resulting into sustained activity, reduced toxicity, protection of active moiety, targeting, modification in distribution profile of drugs and enhancing the bioavailability of encapsulated drug. This article summarizes the merits of niosomal drug delivery system over conventional drug therapy, its structural components, factors affecting its formation, method of preparation, evaluation techniques, therapeutic applications and patents.
Similar content being viewed by others
References
Abd-Elbary A, El-laithy HM, Tadros MI (2008) Sucrose stearate-based proniosome-derived niosomes for the nebulisable delivery of cromolyn sodium. Int J Pharm 357(1–2):189–198. doi:10.1016/j.ijpharm.2008.01.056
Alcantar N, Dearborn K, Van Auker M, Toomey R, Hood E (2008) Niosome hydro gel drug delivery. US patent number US2008/0050445 A1
Alcantar N, Williams EC, Toomey R (2010) Niosome hydrogel drug delivery. US patent number US2010/0068264 A1
Ammar HO, Ghorab M, El-Nahhas SA, Higazy IM (2011) Proniosomes as a carrier system for transdermal delivery of tenoxicam. Int J Pharm 405:142–152. doi:10.1016/j.ijpharm.2010.11.003
Arunothayanun P, Bernard MS, Craig DQ, Uchegbu IF, Florence AT (2000) The effect of processing variables on the physical characteristics of non-ionic surfactant vesicles (niosomes) formed from a hexadecyl diglycerol ether. Int J Pharm 201:7–14
Attia IA, El-Gizawy SA, Fouda MA, Donia AM (2007) Influence of a niosomal formulation on the oral bioavailability of acyclovir in rabbits. AAPS PharmSciTech. doi:10.1208/pt0804106
Baillie AJ, Coombs GH, Dolan TF, Laurie J (1986) Non-ionic surfactant vesicles, niosomes, as a delivery system for the anti-leishmanial drug, sodium stibogluconate. J Pharm Pharmacol 38:502–505
Balakrishnan P, Shanmugam S, Lee WS, Lee WM, Kim JO et al (2009) Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery. Int J Pharm 377:1–8. doi:10.1016/j.ijpharm.2009.04.020
Bhaskaran S, Lakshmi PK (2009) Comparative evaluation of niosome formulations prepared by different techniques. Acta Pharm Sci 51:27–32
Bibi S, Kaur R, Henriksen-Lacey M, Mc Neil SE, Wilkhu J, Lattmann E (2011) Microscopy imaging of liposomes: from cover- slips to environmental SEM. Int J Pharm 417:138–150
Biju SS, Telegaonar S, Mishra PR, Khar RK (2006) Vesicular system: an overview. Indian J Pharm Sci 68:141–153
Biswal S, Murthy PN, Sahu J, Sahoo P, Amir F (2008) Vesicles of non-ionic surfactants (niosomes) and drug delivery potential. Int J Pharm Sci Nanotechnol 1(1):1–8
Blazek Welsh AI, Rhodes DG (2001) SEM imaging predicts quality of niosomes from maltodextrin-based proniosomes. Pharm Res 18(5):656–661
Chauhan S, Luorence MJ (1989) The preparation of polyoxyethylene containing non-ionic surfactant vesicles. J Pharm Pharmacol 41:1–6
Chauhan M, Sharma SK, Anilkumar N (2009) Span-60 niosomal oral suspension of fluconazole: formulation and in vitro evaluation. J Pharm Res Health Care 1(2):142–156
Dahiya NK, Rao R, Nanda S (2011) Preparation and characterization techniques in niosomal vesicular systems—a review. J Pharm Biomed Sci 5:1–8
Gail S, Shenoy DB, Lee RW (2010) Adjuvant and vaccine compositions. US patent number US2010/0226932 A1
Guinedi AS, Mortada ND, Mansour S, Hathout RM (2005) Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide. Int J Pharm 306(1–2):71–82. doi:10.1016/j.ijpharm.2005.09.023
Hall DG (1987) Thermodynamics of micelle formation. In: Schick MJ (ed) Nonionic surfactants: physical chemistry, surfactant science series, vol 23. Marcel Dekker, New York, pp 233–296
Hilgers LA, Zigterman GJWJ, Snippe H (1989) Immunomodulating properties of amphiphilic agents. In: Kammuller ME, Bioksma N, Sienen W (eds) Autoimmunity and toxicology. Elsevier, Amsterdam, pp 294–306
Hood E, Strom JA, Van Auker M (2006) Ultrasound enhancement of drug release across non ionic surfactant membranes. US patent number US2006/0292211 A1
Hunter CA, Dolan TF, Coombs GH, Baillie AJ (1988) Vesicular system (niosomes and liposomes) for delivery of sodium stibogluconate in experimental murine visceral leishmaniasis. J Pharm Pharmacol 40(3):161–165
Indhu PK, Garg A, Anil KS, Aggarwal D (2004) Vesicular system in ocular drug delivery. Indian J Pharm Sci 269:1–14
Jadon PS, Gajbhiye V, Jadon RS, Gajbhiye KR, Ganesh N (2009) Enhanced oral bioavailability of griseofulvin via niosomes. AAPS PharmSciTech 10(4):1186–1192. doi:10.1208/s12249-009-9325-z
Jiao J (2008) Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery. Adv Drug Deliv Rev 60(15):1663–1673. doi:10.1016/j.addr.2008.09.002
Kazi KM, Mandal AS, Biswas N, Guha A, Chatterjee S, Behera M, Kuotsu K (2010) Niosome: a future of targeted drug delivery systems. J Adv Pharm Technol Res 1(4):374–380. doi:10.4103/0110-5558.76435
Khan A, Sharma PK, Visht S, Malviya R (2011) Niosomes as colloidal drug delivery system: a review. J Chronother Drug Deliv 2(1):15–21
Khandare JN, Madhavi G, Tamhankar BM (1994) Niosomes novel drug delivery system. East Pharm 37:61–64
Kumar GP, Rajeshwarrao P (2011) Nonionic surfactant vesicular systems for effective drug delivery-an overview. Acta Pharm Sin B 1(4):208–219. doi:10.1016/j.apsb.2011.09.002
Kumar A, Pal JL, Jaiswal A, Singh V (2011) Review on niosomes as novel drug delivery system. Int Res J Pharm 2(5):61–65
Lawrence J, Chauhan S, Lawrence SM, Barlow D (1996) The formation, characterization and stability of non-ionic surfactant vesicles. STP Pharma Sci 6(1):49–60
Marianecci C, Paolino D, Celia C, Fresta M, Carafa M, Alhaique F (2010) Non-ionic surfactant vesicles in pulmonary glucocorticoid delivery: characterization and interaction with human lungfibro-blasts. J Control Release 147(1):127–135. doi:10.1016/j.jconrel.2010.06.022
Martin JF (1990) Pharmaceutical manufacturing of liposomes. In: Tyle P (ed) Specialized drug delivery systems manufacturing and production technology. Marcel Dekker, New York, pp 267–314
Mokhtar M, Sammour OA, Hammad MA, Megrab NA (2008) Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. Int J Pharm 361(1–2):104–111. doi:10.1016/j.ijpharm.2008.05.031
Mujoriya RZ, Bodla RB (2011) Niosomes—challenge in preparation for pharmaceutical scientist. Int J Appl Pharm 3:11–15
Nasseri B, Florence AT (2003) Microtubules formed by capillary extrusion and fusion of surfactant vesicles. Int J Pharm 266(1–2):91–98. doi:10.1016/S0378-5173(03)00385-5
Palozza P, Muzzalupo R, Trombino S, Valdannini A, Picci N (2006) Solubilization and stabilization of beta-carotene in niosomes: delivery to cultured cells. Chem Phys Lipids 139(1):32–42. doi:10.1016/j.chemphyslip.2005.09.004
Pardakhty A, Varshosaz J, Rouholamini A (2007) In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin. Int J Pharm 328:130–141. doi:10.1016/j.ijpharm.2006.08.002
Parthasarathi G, Udupa N, Umadevi P, Pillai GK (1994) Niosome encapsulated vincristine sulphate: improved anticancer activity with reduced toxicity in mice. J Drug Target 2:173–182. doi:10.3109/10611869409015907
Pavala RN, Suriyaprakash TNK, Senthamarai R (2010) Formulation and evaluation of rifampicin and gatifloxacin niosomes on logarithmic-phase cultures of Mycobacterium tuberculosis. Int J Pharm Biol Sci 1:379–387
Rogerson A, Cummings J, Willmott N, Florence AT (1988) The distribution of doxorubicin in mice following administration in niosomes. J Pharm Pharmacol 40:337–342
Ruckmani K, Sankar V (2010) Formulation and optimization of Zidovudine niosomes. AAPS PharmSciTech 11:1119–1127. doi:10.1208/s12249-010-9480-2
Ruckmani K, Jayakar B, Ghosal SK (2000) Nonionic surfactant vesicles (niosomes) of cytarabine hydrochloride for effective treatment of leukemias: encapsulation, storage, and in vitro release. Drug Dev Ind Pharm 26(2):217–222
Schreier H, Bouwstra J (1994) Liposomes and niosomes as topical drug carriers: dermal and transdermal drug delivery. J Control Release 30:1–15. doi:10.1016/0168-3659(94)90039-6
Shahiwala A, Misra A (2002) Studies in topical application of niosomally entrapped nimesulide. J Pharm Pharm Sci 5:220–225
Shan W, Liu H, Shi J, Yang L, Hu N (2008) Self-assembly of electroactive layer-by-layer films of heme proteins with anionic surfactant dihexadecyl phosphate. Biophys Chem 134:101–109
Stafford S, Ballie AJ, Florence AT (1988) Drug effect on the size of chemically defined nonionic surfactant vesicles. J Pharm Pharmacol 40:26
Terzano C, Allegra L, Alhaique F, Marianecci C, Carafa M (2005) Non-phospholipid vesicles for pulmonary glucocorticoid delivery. Eur J Pharm Biopharm 59:57–62. doi:10.1016/j.ejpb.2004.06.010
Uchegbu IF, Florence AT (1995) Non-ionic surfactant vesicles (niosomes): physical and pharmaceutical chemistry. Adv Colloid Interface Sci 58:1–55
Uchegbu IF, Vyas SP (1998) Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm 172:33–70. doi:10.1016/S0378-5173(98)00169-0
Van Auker M, Plaas A, Hood E (2007) Immuno targeting of non ionic surfactant vesicles. US patent number US2007/0172520 A1
Vyas SP, Khar RK (2002) Controlled drug delivery—concepts and advances. CBS Publisher and Distributor, New Delhi
Wadhe K, Kalsait R, Umekar M (2009) Alternate drug delivery system: recent advancement and future challenges. Arch Pharm Sci Res 1:97–105
Yang CC, Le YC, Liu CC (2005) Compositions and methods of enhanced transdermal delivery of steroid compounds and preparation methods. US patent number US2005/0239747 A1
Yoshioka T, Sternberg B, Florence AT (1994) Preparation and properties of vesicles (niosomes) of sobitan monoesters (Span 20, 40, 60, and 80) and a sorbitan triester (Span 85). Int J Pharm 105:1–6. doi:10.1016/0378-5173(94)90228-3
Zhang S, Morris ME (2005) Efflux transporters in drug excretion. In: Wang B, Siahaan T, Soltero R (eds) Drug delivery: principles and applications. Wiley, Hoboken, pp 381–398
Zografi G (1995) Interfacial phenomena. In: Gennaro AR (ed) Remington: the science and practice of pharmacy, 17th edn. Mark Publishing, Pennsylvania, pp 241–251
Acknowledgments
The authors are thankful to the Institute of Pharmacy, Bundelkhand University, Jhansi, U.P. to provide facility to compile this review. The authors of this publication receive no funding for this research work, the authors Rizwana Khan and Raghuveer Irchhaiya have no conflict of interests.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Khan, R., Irchhaiya, R. Niosomes: a potential tool for novel drug delivery. Journal of Pharmaceutical Investigation 46, 195–204 (2016). https://doi.org/10.1007/s40005-016-0249-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40005-016-0249-9